Profile data is unavailable for this security.
About the company
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
- Revenue in USD (TTM)7.34bn
- Net income in USD609.50m
- Incorporated2016
- Employees14.50k
- LocationAvantor IncBuilding One100 W Matsonford Rd Ste 200RADNOR 19087United StatesUSA
- Phone+1 (610) 386-1700
- Fax+1 (302) 636-5454
- Websitehttps://www.avantorsciences.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Itron Inc | 1.81bn | -22.47m | 3.30bn | 5.48k | -- | 2.82 | 78.75 | 1.82 | -0.4992 | -0.4992 | 40.14 | 25.80 | 0.746 | 5.83 | 5.96 | 331,358.60 | -0.924 | -1.50 | -1.19 | -1.97 | 29.94 | 29.37 | -1.24 | -1.74 | 1.19 | 15.45 | 0.2751 | -- | -9.39 | -2.31 | 88.02 | -- | -16.79 | -- |
| Integra Lifesciences Holdings Corp | 1.56bn | 171.88m | 3.35bn | 3.72k | 19.83 | 2.00 | 11.50 | 2.15 | 2.07 | 2.07 | 18.79 | 20.45 | 0.4213 | 1.71 | 6.12 | 419,633.00 | 4.64 | 3.42 | 5.04 | 3.79 | 62.90 | 63.77 | 11.00 | 7.97 | 2.40 | 8.21 | 0.4622 | 0.00 | 0.9866 | 5.56 | 6.79 | 10.79 | 1.60 | -- |
| Badger Meter Inc | 592.27m | 71.55m | 4.43bn | 1.98k | 62.04 | 9.67 | 45.19 | 7.48 | 2.43 | 2.43 | 20.15 | 15.62 | 1.00 | 3.06 | 7.29 | 299,730.30 | 12.13 | 10.88 | 14.68 | 12.94 | 39.18 | 39.05 | 12.08 | 10.69 | 1.97 | -- | 0.00 | 40.66 | 11.95 | 7.04 | 9.22 | 13.46 | -17.13 | 11.65 |
| Vontier Corp | 3.21bn | 233.90m | 4.82bn | 8.10k | 20.88 | 7.57 | 13.57 | 1.50 | 1.48 | 1.48 | 20.29 | 4.09 | 0.749 | 5.23 | 7.10 | 396,629.60 | 5.45 | -- | 6.84 | -- | 45.01 | 43.89 | 7.28 | 13.83 | 1.12 | 2.29 | 0.7981 | 1.44 | 6.48 | 4.97 | -2.83 | 1.43 | -2.59 | -- |
| MKS Instruments Inc | 3.60bn | 148.00m | 6.76bn | 10.90k | 38.85 | 1.52 | 15.26 | 1.88 | 2.61 | 2.61 | 57.49 | 66.73 | 0.4495 | 2.42 | 6.54 | 330,183.50 | 1.85 | 8.25 | 2.01 | 9.11 | 43.01 | 45.20 | 4.11 | 13.80 | 1.93 | 2.06 | 0.5253 | 12.99 | 20.25 | 13.11 | -39.61 | -0.6092 | 39.28 | 4.53 |
| Cognex Corporation | 924.81m | 173.81m | 9.58bn | 2.44k | 55.66 | 6.62 | 49.53 | 10.36 | 0.9971 | 0.9971 | 5.31 | 8.38 | 0.4733 | 1.99 | 6.10 | 378,864.00 | 8.89 | 12.85 | 9.93 | 13.96 | 71.59 | 73.47 | 18.79 | 25.21 | 2.78 | -- | 0.00 | 49.44 | -2.99 | 5.60 | -22.99 | -5.80 | -7.32 | 9.61 |
| Bio Rad Laboratories Inc | 2.78bn | -188.96m | 10.70bn | 8.20k | -- | 1.09 | -- | 3.85 | -6.25 | -6.25 | 93.45 | 329.76 | 0.1982 | 1.84 | 5.78 | 338,906.20 | -1.35 | 12.23 | -1.41 | 13.01 | 54.97 | 55.62 | -6.80 | 50.63 | 4.28 | 0.6605 | 0.1093 | 0.00 | -4.12 | 5.34 | -185.27 | -- | 0.2591 | -- |
| Bruker Corporation | 2.62bn | 311.50m | 10.87bn | 8.53k | 35.26 | 9.21 | 26.87 | 4.15 | 2.10 | 2.10 | 17.65 | 8.04 | 0.7167 | 1.58 | 5.92 | 307,448.70 | 8.53 | 7.78 | 11.70 | 10.57 | 51.89 | 49.08 | 11.91 | 10.26 | 1.22 | 19.04 | 0.5038 | 11.61 | 4.67 | 7.46 | 7.04 | 14.99 | 24.21 | 4.56 |
| Avantor Inc | 7.34bn | 609.50m | 13.39bn | 14.50k | 22.08 | 2.68 | 13.37 | 1.82 | 0.8981 | 0.8981 | 10.82 | 7.40 | 0.5392 | 5.34 | 5.60 | 506,365.50 | 4.54 | 2.45 | 5.12 | 2.76 | 34.56 | 32.91 | 8.41 | 4.09 | 1.03 | 3.85 | 0.5482 | 0.00 | 1.71 | 43.20 | 30.37 | -- | 39.56 | -- |
| Revvity Inc | 2.73bn | 360.52m | 13.98bn | 16.70k | 39.09 | 1.75 | 18.00 | 5.13 | 2.85 | 7.60 | 21.56 | 63.77 | 0.185 | 1.93 | 3.57 | 163,308.10 | 2.45 | 5.70 | 2.70 | 6.50 | 62.04 | 55.90 | 13.22 | 15.65 | 2.15 | 6.27 | 0.3518 | 6.23 | -13.48 | 7.97 | -42.36 | 14.24 | 16.98 | 0.00 |
| Waters Corporation | 2.97bn | 688.85m | 14.76bn | 8.20k | 21.74 | 24.59 | 18.04 | 4.97 | 11.50 | 11.50 | 49.50 | 10.16 | 0.9345 | 2.83 | 4.60 | 361,714.40 | 21.70 | 18.80 | 28.36 | 23.36 | 57.96 | 58.35 | 23.22 | 23.99 | 1.59 | 21.73 | 0.7116 | 0.00 | 6.68 | 5.18 | 2.15 | 4.41 | 15.19 | -- |
| Fortive Corp | 5.91bn | 763.70m | 24.18bn | 18.00k | 32.05 | 2.45 | 19.75 | 4.09 | 2.13 | 2.13 | 16.52 | 27.92 | 0.3686 | 4.43 | 6.32 | 328,327.80 | 4.76 | 4.68 | 5.68 | 5.78 | 57.86 | 56.68 | 12.92 | 14.79 | 0.7167 | 9.41 | 0.2386 | 14.37 | 10.87 | 0.2407 | 30.27 | -1.50 | -2.92 | 0.00 |
Data as of Jun 08 2023. Currency figures normalised to Avantor Inc's reporting currency: US Dollar USD
42.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2023 | 76.07m | 11.28% |
| The Vanguard Group, Inc.as of 31 Mar 2023 | 61.26m | 9.08% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2023 | 30.07m | 4.46% |
| BlackRock Fund Advisorsas of 31 Mar 2023 | 24.66m | 3.66% |
| Canada Pension Plan Investment Boardas of 31 Mar 2023 | 24.37m | 3.61% |
| Boston Partners Global Investors, Inc.as of 31 Mar 2023 | 16.39m | 2.43% |
| Barrow, Hanley, Mewhinney & Strauss LLCas of 31 Mar 2023 | 16.19m | 2.40% |
| American Century Investment Management, Inc.as of 31 Mar 2023 | 15.11m | 2.24% |
| Janus Henderson Investors US LLCas of 31 Mar 2023 | 12.94m | 1.92% |
| Wellington Management Co. LLPas of 31 Mar 2023 | 12.65m | 1.88% |
More ▼
Data from 31 Mar 2023 - 31 Mar 2023Source: FactSet Research Systems Inc.
